Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status
Ahmed Alafandi, Karin A. van Garderen, Stefan Klein, Sebastian R. van der Voort, D. Rizopoulos, Burt Nabors, Roger Stupp, Michael Weller, Thierry Gorlia, Joerg‐Christian Tonn, Marion Smits
Topics & Concepts
MedicineTemozolomideHazard ratioRadiation therapyOncologyInternal medicineChemoradiotherapyMethyltransferaseChemotherapyO-6-methylguanine-DNA methyltransferaseMagnetic resonance imagingPerformance statusConfidence intervalGlioblastomaMethylationRadiologyCancer researchBiologyGeneBiochemistryGlioma Diagnosis and TreatmentBrain Metastases and TreatmentEpigenetics and DNA Methylation